Tuesday, December 22, 2009

Tumor marker examination of thyroid cancer

The human body is like a magic machine, when a certain part of the machine when problems occur, the body will appear to remind us of some small state's attention. However, the daily busy life whether you turn a blind eye to these health warning out? Xiao Bian specifically for the busy home life for you have identified a full range of knowledge, hoping to make your every day off healthy and happy.

According to pathological type of thyroid cancer is divided into: Thyroid papillary carcinoma, follicular carcinoma, medullary carcinoma and undifferentiated carcinoma in 4 categories. Only medullary thyroid carcinoma with a clinical diagnosis of specific markers of a calcitonin (CT) (positive standard greater than or equal 300pg/ml). Medullary thyroid carcinoma is a rare malignant tumor derived from thyroid C cells.

In all patients with medullary thyroid carcinoma have increased levels of serum calcitonin.

Therefore, surgical treatment of medullary thyroid carcinoma and / or the incident after treatment, serum calcitonin can monitor the transfer of clinical recurrence or metastasis has to determine prognosis and treatment effects of the sustained high calcitonin to keep a close observation of patients with follow-up .

Follicular thyroid cancer, especially adenocarcinoma associated markers of thyroglobulin (TG). It is the follicular thyroid carcinoma damage detection and treatment targets. Normal serum TG of less than 60ng/ml. If the TG continued to increase indicates a possible tumor recurrence or metastasis.

No comments:

Post a Comment